Azitra

Azitra Stock-Based Compensation

The Stock-Based Compensation (SBC) of Azitra (AZTR) as of Oct 21, 2026 is 62,744.00 USD. In the previous year, Stock-Based Compensation (SBC) was 245,053.00 USD — a change of -74.40% (lower).

Stock-Based Compensation

62,744.00USD

YoY

-74.40%

Last updated:

Stock-Based Compensation (SBC) of Azitra is 2025 62,744.00 USD. Stock-Based Compensation (SBC) of Azitra was 2024 245,053.00 USD. It decreases by -74.40% lower compared to the previous year.

The Azitra Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2021
306,055.00 USD
Jan 1, 2022
184,465.00 USD
Jan 1, 2023
151,505.00 USD
Jan 1, 2024
245,053.00 USD
Jan 1, 2025
62,744.00 USD
The Azitra Stock-Based Compensation history
YEARStock-Based CompensationYoY
62,744.00USD-74.40%
245,053.00USD+61.75%
151,505.00USD-17.87%
184,465.00USD-39.73%
306,055.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Azitra Stock analysis

What does Azitra do? Azitra Inc., based in Branford, Connecticut, is an early-stage biopharmaceutical company focused on developing topical therapies for dermatological conditions. The company utilizes engineered proteins and live biotherapeutic products, leveraging a microbial library of 1,500 bacterial strains and AI-driven screening to create treatments for skin diseases. Its pipeline includes ATR-12 for Netherton syndrome, ATR-04 for papulopustular rash, and ATR-01 for ichthyosis vulgaris, all targeting unmet medical needs in precision dermatology. Listed on June 16, 2023, Azitra operates with a team of 10 employees. Azitra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Azitra stock

Stock-Based Compensation (SBC) of Azitra is 62,744.00 USD in 2025.

Stock-Based Compensation (SBC) of Azitra changed from 245,053.00 USD to 62,744.00 USD, representing a -74.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Azitra since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Azitra historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Azitra

All Key Metrics — Azitra